Xishan Technology announced on May 6, 2024 that the number of shareholders of the company as of April 30, 2024 was 4,662, an increase of 46 or 1.00% from the previous period (April 19, 2024).
The number of shareholders of Xishan Technology is lower than the industry average. According to Choice data, as of April 30, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry was 33,900. Among them, the number of shareholders of the company is in the range of 5,000~15,000, accounting for the highest proportion, 28.84%.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since March 20, 2024, the number of shareholders of the company has decreased significantly, with a decrease of 13.59%. From March 20, 2024 to April 30, 2024, the stock price decreased by 14.14%.
Number of shareholders and share price
Number of shareholders and share capital
As of April 30, 2024, the company's latest total share capital is 53,001,500 shares, of which the outstanding share capital is 12,818,700 shares. The average number of outstanding shares held by households decreased from 2,777 shares in the previous period to 2,750 shares, and the average market value of households was 195,800 yuan.
The average amount of shares held by each household
The average circulating market value of Xishan Technology households is lower than the industry average. According to Choice data, as of April 30, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry was 401,400 yuan. Among them, 25.31% of the company's households hold a circulating stock market value of 130,000~250,000 yuan, and Xishan Technology is also in the range.
Distribution of per capita circulating market value of the pharmaceutical and biological industry
Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.